english türkçe
PTH

Description

Prothrombin G20210A mutation

Intended Use

Venous thrombosis is among the three most common cardiovascular diseases, affecting about 1 in 1000 individuals each year. Thrombotic risk is determined both by circumstantial factors (age, surgery, pregnancy, oral contraception), as well as by genetic predisposition. Common point mutation in the 3´-untranslated region of the prothrombin (factor II) gene (20210: G>A) has been reported to be associated with elevated plasma prothrombin levels and is estimated to increase the risk for venous thrombosis by 3 to 5-fold



Copyright © 2009 - 2019 İnvitrotek A.Ş. All Right Reserved by Invitrotek

Copyright © 2009 - 2019 İnvitrotek A.Ş. All Right Reserved by Invitrotek
Powered by EOS